|
|
Cancer Therapeutic/Diagnosis Market Research
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Cancer Therapeutic/Diagnosis, including, but not limited to market trend on therapeutic of: Lung Cancer; Melanoma; Colorectal Cancer; Breast Cancer; Tumor; Cervical Cancer; Ovarian Cancer; Myeloma; Pancreatic Cancer and new Anticancer therapeutic like Immunotherapies; Angiogenesis Inhibitors; Protein Kinase Inhibitors.
We offer market research, industry forecasts, and business analysis in the Cancer Therapeutic/Diagnosis as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
Reports
| Biomarker Technology Platforms for Cancer Diagnoses and Therapies |
|
| Published : 2008/04 |
| Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, col ... |
| Companion Diagnostics in Personalized Medicine and Cancer Therapy |
|
| Published : 2008/04 |
| A near-term market opportunity for cancer companion diagnostic tests exists in drug selection for cancer therapy. Co-development of molecular diagnostics and targeted therapeutics has already been proven to be a successful strategy in the development of n ... |
| Cancer Brain Tumor |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Brain Tumor contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developmen ... |
| Cancer Breast Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Breast Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developm ... |
| Cancer Cell Therapy Markets |
|
| Published : 2008/03 |
| Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the inhibition of cancer cell proliferation. ... |
| Cancer Colorectal Cancer or Colon Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Colorectal Cancer or Colon Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ... |
| Cancer Head and Neck Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Head and Neck Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and d ... |
| Cancer Kidney Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Kidney Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developm ... |
| Cancer Liver Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Liver Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developme ... |
| Cancer Melanoma or Skin Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Melanoma or Skin Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news an ... |
| Cancer Multiple Myeloma |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Multiple Myeloma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and devel ... |
| Cancer Non-Hodgkin Lymphoma |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Non-Hodgkin Lymphoma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and d ... |
| Cancer Ovarian Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Ovarian Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and develop ... |
| Cancer Pancreatic Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Pancreatic Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and deve ... |
| Cancer Prostate Cancer |
|
| Published : 2008/03 |
| Life Science Analytics' , Cancer Prostate Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and develo ... |
| NGN Drivers and Inhibitors in the Global Market |
|
| Published : 2008/03 |
| A few years ago, IMS was all the rage. Today, the term is hardly ever mentioned. Has the migration to NGNs ceased, or has it simply changed form? This research report examines the current state of NGN development and explores the reasons why operators are ... |
| The Worldwide Market for Cancer Diagnostics, 3rd Edition |
|
| Published : 2008/03 |
| Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics, the use of mul ... |
| U.S. Breast Cancer Therapeutics Markets |
|
| Published : 2008/03 |
| This research service explores the market for therapeutics used for the treatment of breast cancer in the Unites States of America. It analyzes the various challenges faced by pharmaceutical companies, and the competitive advantages and disadvantages of t ... |
| The Drug Target Atlas of Apoptopic Drugs in Oncology |
|
| Published : 2008/02 |
| In the report, BioSeeker reports on 90 unique drug target combinations, each comprised of a different collection or mix of individually defined targets, for 114 apoptopic drugs designed for the treatment of 48 different cancer indications. The highest deg ... |
| Antibody Drug Targets and Special Focus on Leukemias & Lymphomas |
|
| Published : 2007/12 |
| In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Leukemias and Lymphomas, which are all subjects to an extensive number of innovative drug candidates. This extensive 430+ pa ... |
| Who's Developing What in New Cancer Drugs 2007? |
|
| Published : 2007/11 |
| The new 6th edition of this respected management report is the essential reference work for everyone in the field. The report covers 121 companies - from the largest blue-chip multinational to smaller specialist organisations - and all phases of developme ... |
| Cancer Vaccine Developments to 2013 |
|
| Published : 2007/09 |
| This insightful and data-rich management report Cancer Vaccine Developments to 2013, fully evaluates the products and their developers. In more than 180 pages, the report provides a complete review of the market and its likely development to 2013. ... |
| Decoding Big Pharmas R&D Strategy in Oncology |
|
| Published : 2007/09 |
| This report, Decoding Big Pharma' s R&D Strategy in Oncology, is based on five major pharmaceutical companies in the oncology arena: Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Between them and together with their respect ... |
| Developments in Cancer Vaccine Industry |
|
| Published : 2007/09 |
| This research service analyses the latest developments that has occurred in the field of cancer vaccines, both from a technology and industry perspective. ... |
| European Bladder Cancer Therapeutics Markets |
|
| Published : 2007/08 |
| This Frost & Sullivan research service titled European Bladder Cancer Therapeutics Markets presents a concise analysis of the market that includes challenges, factors driving growth and the revenue forecasts from 2003 to 2013. ... |
| European Head and Neck Cancer Therapeutics Markets |
|
| Published : 2007/08 |
| This Frost & Sullivan research service titled European Head and Neck Cancer Therapeutics Markets provides market drivers, restraints and revenue forecasts for this market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the chemot ... |
| Melanoma - Targeted Therapeutics |
|
| Published : 2007/07 |
| The risk of malignant melanoma has more than doubled in the past decade. The incidence of melanoma is rising faster than that of any other cancer. ... |
| Antibody Drug Target Atlas in Oncology |
|
| Published : 2007/06 |
| The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy in cancer. ... |
Annual Information Services
|
|
View Cart
